{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:37:10Z","timestamp":1790480230893,"version":"4.1.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1992,5,1]],"date-time":"1992-05-01T00:00:00Z","timestamp":704678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>The in vivo role of interferons in the development of fibrosis is not fully understood but it is known that interferons can suppress fibroblast proliferation and collagen synthesis in vitro. We have recently demonstrated that in a group of patients with sarcoidosis having predominant pulmonary involvement, patients with the highest levels of circulating interferon-gamma (IFN-y) more frequently resolved on corticosteroids, suggesting that they had a less\u2018fibrotic\u2019 component to their disease. We now report that in two other diseases, where the tendency to develop pulmonary fibrosis is greater than in sarcoidosis, namely cryptogenic fibrosing alveolitis (CFA) and fibrosing alveolitis associated with the systemic connective tissue disease progressive systemic sclerosis (FA + PSS), very few patients have elevations in IFN-\u03b3 in their serum. However, as in sarcoidosis, those with the highest levels responded to corticosteroids (P &amp;lt; 0\u00b705). Attempts to measure IFN-\u03b3 levels in the lungs, using cell-free bronchoalveolar lavage (BAL) fluid supernatants, were negative in all the study groups, suggesting that these samples may be inadequate for such studies. To investigate whether there might be an intrinsic defect in T lymphocyte function associated with predisposition to fibrosing lung diseases, we then investigated the in vitro production of IFN-y by lymphocytes separated from the blood of 18 untreated patients (six with CFA, six with FA + PSS and six with sarcoidosis). IFN-\u03b3 production was impaired in 10 (56%) (two with CFA, four with FA + PSS and four with sarcoidosis). A higher proportion of the fibrosing alveolitis patients (CFA or FA + PSS) with impaired IFN-\u03b3 production have subsequently shown spontaneous lung functional deterioration. These findings suggest that impaired IFN-\u03b3 release might be a potentiating factor in the pathogenesis of these fibrosing lung diseases.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1992.tb03074.x","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T12:20:23Z","timestamp":1280406023000},"page":"280-287","source":"Crossref","is-referenced-by-count":88,"title":["<i>In vivo<\/i> levels and <i>in vitro<\/i> production of interferon-gamma in fibrosing interstitial lung diseases"],"prefix":"10.1093","volume":"88","author":[{"given":"C","family":"PRIOR","sequence":"first","affiliation":[{"name":"Cell Biology Group, Department of Cardiothoracic Surgery, National Heart and Lung Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L","family":"HASLAM","sequence":"additional","affiliation":[{"name":"Cell Biology Group, Department of Cardiothoracic Surgery, National Heart and Lung Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011703313742200_b1","first-page":"457","article-title":"An introduction to the interstitial lung diseases","volume-title":"Clinics in chest medicine","author":"Fulmer","year":"1982"},{"key":"2022011703313742200_b2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-2971-6","volume-title":"Sarcoidosis","author":"Scadding","year":"1985","edition":"2nd Edn."},{"key":"2022011703313742200_b3","first-page":"199","article-title":"State of the art: granuloma to fibrosis","volume-title":"Sarcoidosis and other granulomatous disorders","author":"Jones-Williams","year":"1983"},{"key":"2022011703313742200_b4","first-page":"L159","article-title":"Pathobiology of pulmonary fibrosis","volume":"259","author":"Crouch","year":"1990","journal-title":"Am J Physiol"},{"key":"2022011703313742200_b5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/thx.35.3.171","article-title":"Cryptogenic fibrosing alveolitis: clinical features and their influence on survival","volume":"35","author":"Turner-Warwick","year":"1980","journal-title":"Thorax"},{"key":"2022011703313742200_b6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1378\/chest.97.6.1439","article-title":"Cytokine networks in the regulation of inflammation and fibrosis in the lung","volume":"97","author":"Elias","year":"1990","journal-title":"Chest"},{"key":"2022011703313742200_b7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-291X(84)90422-4","article-title":"Transcriptional control of human diploid fibroblast collagen synthesis by gamma-intereron","volume":"123","author":"Rosenbloom","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"2022011703313742200_b8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-5793(85)80227-1","article-title":"Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of the procollagen mRNAs","volume":"180","author":"Stephenson","year":"1985","journal-title":"FEBS Lett"},{"key":"2022011703313742200_b9","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.1016\/S0021-9258(18)45207-6","article-title":"Differential effects of gamma-interferon on collagen and fibronectin gene expression","volume":"262","author":"Czaja","year":"1987","journal-title":"J Biol Chem"},{"key":"2022011703313742200_b10","first-page":"62","article-title":"Recombinant gamma, alpha and beta interferon regulation of human lung fibroblast prolifer ation","volume":"135","author":"Elias","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2022011703313742200_b11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/ajrccm\/138.3.652","article-title":"Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prosta-glandin-dependent and -independent mechanisms","volume":"138","author":"Elias","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"2022011703313742200_b12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1164\/ajrccm\/143.1.53","article-title":"Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy","volume":"143","author":"Prior","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2022011703313742200_b13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(69)92392-7","article-title":"A transmissible agent from sarcoid tissue","volume":"ii","author":"Mitchell","year":"1969","journal-title":"Lancet"},{"key":"2022011703313742200_b14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(84)90702-5","article-title":"Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association","volume":"ii","author":"Vergnon","year":"1984","journal-title":"Lancet"},{"key":"2022011703313742200_b15","first-page":"1151","article-title":"Lupus erythematosus, scleroderma and dermato-myositis. The \u2018collagen\u2019 or \u2018connective tissue\u2019 diseases","volume-title":"Textbook of dermatology","author":"Rowell","year":"1979"},{"issue":"suppl. 4","key":"2022011703313742200_b16","first-page":"35","article-title":"Imaging fibrosing alveolitis","volume":"4","author":"Strickland","year":"1988","journal-title":"Postgrad Med J"},{"key":"2022011703313742200_b17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheuma tism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022011703313742200_b18","volume-title":"Lung Function","author":"Cotes","year":"1979"},{"key":"2022011703313742200_b19","first-page":"1","article-title":"Cryptogenic fibrosing alveolitis: relationship of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis","volume":"124","author":"Rudd","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"2022011703313742200_b20","first-page":"26","article-title":"The value of serial bronchoalveolar lavage in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis","volume":"135","author":"Turner-Warwick","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2022011703313742200_b21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/clinchem\/31.6.1090a","article-title":"A sensitive immunoradiometric assay for gammainterferon, suitable for its measurement in serum","volume":"31","author":"Woloszczuk","year":"1985","journal-title":"Clin Chem"},{"key":"2022011703313742200_b22","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1073\/pnas.81.16.5219","article-title":"Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon","volume":"81","author":"Chang","year":"1984","journal-title":"Proc Nat Acad Sci USA"},{"key":"2022011703313742200_b23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-4827(79)90450-6","article-title":"Interferon effects on the growth and division of human fibroblasts","volume":"121","author":"Pfeffer","year":"1979","journal-title":"Exp Cell Res"},{"key":"2022011703313742200_b24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1084\/jem.162.2.516","article-title":"Gamma interferon is the lymphokine and \u03b2 interferon is the monokine responsible or the inhibition of fibroblast collagen production and late but not early fibroblast prolifer ation","volume":"112","author":"Duncan","year":"1985","journal-title":"J Exp Med"},{"key":"2022011703313742200_b25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1084\/jem.163.3.632","article-title":"Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors","volume":"163","author":"Vilcek","year":"1986","journal-title":"J Exp Med"},{"key":"2022011703313742200_b26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/01902148809087837","article-title":"Effect of murine gamma interferon on the cellular responses to bleomycin in mice","volume":"14","author":"Hyde","year":"1988","journal-title":"Exp Lung Res"},{"key":"2022011703313742200_b27","first-page":"85","article-title":"Interferon system in patients with sarcoidosis: detection of gamma-interferon in granulomatous lymph nodes obtained from the patients","volume":"6","author":"Minagawa","year":"1989","journal-title":"Sarcoidosis"},{"key":"2022011703313742200_b28","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1172\/JCI111852","article-title":"Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis","volume":"75","author":"Robinson","year":"1985","journal-title":"J Clin Invest"},{"key":"2022011703313742200_b29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1378\/chest.89.5.657","article-title":"Interferon and growth factor activity for human lung fibroblasts. Release from bronchoalveolar cells from patients with active sarcoidosis","volume":"89","author":"Mosley","year":"1986","journal-title":"Chest"},{"key":"2022011703313742200_b30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1378\/chest.89.3_Supplement.181S","article-title":"Production of immune (gamma) interferon by bronchoalveolar cells and peripheral blood mononuclear cells or subjects with sarcoidosis","volume":"89","author":"Flint","year":"1986","journal-title":"Chest"},{"key":"2022011703313742200_b31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.iy.06.040188.002255","article-title":"Regulation of cytokine gene expression","volume":"6","author":"Taniguchi","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"2022011703313742200_b32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0090-1229(86)90025-5","article-title":"Usual interstitial pneumonitis is a T-cell alveolitis","volume":"40","author":"Kradin","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"issue":"Suppl.","key":"2022011703313742200_b33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/BF02718236","article-title":"Evaluation of alveolitis by studies of lung biopsies","volume":"168","author":"Haslam","year":"1990","journal-title":"Lung"},{"key":"2022011703313742200_b34","first-page":"341","article-title":"Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis","volume":"13","author":"Andrews","year":"1986","journal-title":"J Rheumatol"},{"key":"2022011703313742200_b35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/thx.45.2.105","article-title":"Pulmonary gamma-interferon produc tion in patients with fibrosing alveolitis","volume":"45","author":"Robinson","year":"1990","journal-title":"Thorax"},{"key":"2022011703313742200_b36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/thx.43.5.354","article-title":"Immunoregulatory proper ties of pulmonary surfactant: effect of lung lining fluid on prolifer ation of human blood lymphocytes","volume":"43","author":"Wilsher","year":"1988","journal-title":"Thorax"},{"key":"2022011703313742200_b37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/thx.45.1.3","article-title":"Immunosuppression by pulmonary surfactant: mechanisms of action","volume":"45","author":"Wilsher","year":"1990","journal-title":"Thorax"},{"key":"2022011703313742200_b38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI111688","article-title":"Enhanced alveolar macrophage-mediated antigen-induced T lymphocyte proliferation in sarcoido sis","volume":"75","author":"Venet","year":"1985","journal-title":"J Clin Invest"},{"key":"2022011703313742200_b39","first-page":"261","article-title":"Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages","volume":"63","author":"Holt","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"2022011703313742200_b40","first-page":"1","article-title":"Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis","volume":"123","author":"Hancock","year":"1986","journal-title":"Am J Pathol"},{"key":"2022011703313742200_b41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3181\/00379727-178-42024","article-title":"Inactivation of interferon by serum and synovial fluids","volume":"178","author":"O'Kelly","year":"1985","journal-title":"Proc Soc Exp Biol Med"},{"key":"2022011703313742200_b42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-3083.1988.tb02324.x","article-title":"Impaired mitogen-induced interferon-gamma production in rheumatoid arthritis and related diseases","volume":"27","author":"Stolzenburg","year":"1988","journal-title":"Scand J Immunol"},{"key":"2022011703313742200_b43","first-page":"203","article-title":"Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis","volume":"17","author":"Franchimont","year":"1988","journal-title":"Scand J Immunol"},{"key":"2022011703313742200_b44","first-page":"294","article-title":"Interleukin-1 production by mononuclear cells from patients with scleroderma","volume":"60","author":"Sandborg","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"2022011703313742200_b45","first-page":"312","article-title":"Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma","volume":"66","author":"Sandborg","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"2022011703313742200_b46","first-page":"666","article-title":"Sponta neous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma","volume":"59","author":"Alcocer-Varela","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"2022011703313742200_b47","first-page":"1","article-title":"Differentiation between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular diseases by comparison of the ratio of OKT4+ cells and OKT8+ cells in BALF T lymphocytes","volume":"67","author":"Nagai","year":"1985","journal-title":"Eur J Respir Dis"},{"key":"2022011703313742200_b48","first-page":"930","article-title":"Changes in circulating monocytes in patients with progressive systemic sclerosis","volume":"14","author":"Andrews","year":"1987","journal-title":"J Rheu matol"},{"key":"2022011703313742200_b49","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2249.1990.tb05340.x","article-title":"Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis","volume":"81","author":"Famularo","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2022011703313742200_b50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0090-1229(90)90147-I","article-title":"Soluble and cellular markers of immune activation in patients with systemic sclerosis","volume":"56","author":"Degiannis","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703313742200_b51","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.159.6.1741","article-title":"Effects of \u03b2 interferon on human fibroblasts at different population doubling levels","volume":"159","author":"Jasny","year":"1984","journal-title":"J Exp Med"},{"key":"2022011703313742200_b52","first-page":"8","volume-title":"Cytokines in cancer therapy","author":"Balkwill","year":"1989"},{"key":"2022011703313742200_b53","first-page":"236","article-title":"Interferon","volume-title":"Textbook of medical virology","author":"Stranneg\u00e4rd","year":"1983"},{"key":"2022011703313742200_b54","first-page":"68","article-title":"Serological association of a new herpes virus (HBLV) with sarcoidosis","volume-title":"Abstracts of XI WCS","author":"Ablashi","year":"1987"},{"key":"2022011703313742200_b55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0002-9343(89)80150-0","article-title":"Recombinant interferon-gamma in the treatment of systemic sclerosis","volume":"87","author":"Kahan","year":"1989","journal-title":"Am J Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1992.tb03074.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/88\/2\/280\/42213194\/j.1365-2249.1992.tb03074.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/88\/2\/280\/42213194\/j.1365-2249.1992.tb03074.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T03:33:00Z","timestamp":1642390380000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/88\/2\/280\/6488168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1992.tb03074.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1992,5]]},"published":{"date-parts":[[1992,5]]}}}